Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA? (Q37780300)

23 August 2017

0 references

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA? (English)

1 reference

23 August 2017

Randy Q Cron

1

0 references

Timothy Beukelman

series ordinal

2

object named as

Timothy Beukelman

1 reference

23 August 2017

16 August 2010

1 reference

Pediatric Rheumatology Online Journal

23 August 2017

1 reference

23 August 2017

8

1 reference

23 August 2017

23

1 reference

Creative Commons Attribution 2.0 Generic

23 August 2017

start time

16 August 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1546-0096-8-23

0 references

cites work

Summary of worldwide pediatric malignancies reported after exposure to etanercept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Incidence of lymphoma in patients with rheumatoid arthritis: a systematic review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Prognosis and primary therapy in peripheral T-cell lymphomas

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931479

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20712883

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20712883

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20712883

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1546-0096-8-23

1 reference

PMCID

2931479

Dimensions Publication ID

23 August 2017

0 references

1 reference

23 August 2017

1 reference

PMCID

2931479